| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Dr. Lipton), Epidemiology, and Social Medicine, Albert Einstein College of Medicine, and Headache Unit, Montefiore Medical College, Bronx, NY; Innovative Medical Research (Drs. Lipton, Kolodner, Liberman, and Stewart), Towson, and Neuroepidemiology Branch (Dr. Scher), National Institute of Neurological Disorders and Stroke, National Institutes of Health, and Johns Hopkins School of Public Health (Drs. Scher and Stewart), Baltimore, MD; and Division of Neuroscience (Dr. Steiner), Imperial College School of Medicine, London, UK.
Address correspondence and reprint requests to Dr. Richard B. Lipton, Innovative Medical Research, 1200 High Ridge Rd., Stamford, CT 06905; e-mail: rlipton{at}imrinc.com
Objective: To determine the prevalence and distribution of migraine in the United States as well as current patterns of health care use.
Methods: A random-digit-dial, computer-assisted telephone interview (CATI) survey was conducted in Philadelphia County, PA, in 1998. The CATI identifies individuals with migraine (categories 1.1 and 1.2) as defined by the diagnostic criteria of the International Headache Society with high sensitivity (85%) and specificity (96%). Interviews were completed in 4,376 subjects to identify 568 with migraine. Those with 6 or more attacks per year (n = 410) were invited to participate in a follow-up interview about health care utilization and family impact of migraine; 246 (60.0%) participated.
Results: The 1-year prevalence of migraine was 17.2% in females and 6.0% in males. Prevalence was highest between the ages of 30 and 49. Whereas 48% of migraine sufferers had seen a doctor for headache within the last year (current consulters), 31% had never done so in their lifetimes and 21% had not seen a doctor for headache for at least 1 year (lapsed consulters). Of current or lapsed consulters, 73% reported a physician-made diagnosis of migraine; treatments varied. Of all migraine sufferers, 49% were treated with over-the-counter medications only, 23% with prescription medication only, 23% with both, and 5% with no medications at all.
Conclusion: Relative to prior cross-sectional surveys, epidemiologic profiles for migraine have remained stable in the United States over the last decade. Self-reported rates of current medical consultation have more than doubled. Moderate increases were seen in the percentage of migraine sufferers who use prescription medications and in the likelihood of receiving a physician diagnosis of migraine.
This article has been cited by other articles:
|
|
 |
|
  E. Tronvik, L. J. Stovner, K. Hagen, J. Holmen, and J-A Zwart High pulse pressure protects against headache: Prospective and cross-sectional data (HUNT study) Neurology, April 15, 2008; 70(16): 1329 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Siva, M. Zarifoglu, M. Ertas, S. Saip, H. N. Karli, B. Baykan, A. Keskinaslan, and M. Senocak Validity of the ID-Migraine screener in the workplace Neurology, April 15, 2008; 70(16): 1337 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kalaydjian, P. P. Zandi, K. L. Swartz, W. W. Eaton, and C. Lyketsos How migraines impact cognitive function: Findings from the Baltimore ECA Neurology, April 24, 2007; 68(17): 1417 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Staab and M. J. Ruckenstein Expanding the Differential Diagnosis of Chronic Dizziness Arch Otolaryngol Head Neck Surg, February 1, 2007; 133(2): 170 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology, January 30, 2007; 68(5): 326 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Detsky, D. R. McDonald, M. O. Baerlocher, G. A. Tomlinson, D. C. McCrory, and C. M. Booth Does this patient with headache have a migraine or need neuroimaging? JAMA, September 13, 2006; 296(10): 1274 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Bigal, J. N. Liberman, and R. B. Lipton Age-dependent prevalence and clinical features of migraine. Neurology, July 25, 2006; 67(2): 246 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Anttila, L. Metsahonkala, and M. Sillanpaa Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics, June 1, 2006; 117(6): e1197 - e1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kidd The prevalence of headache in Behcet's syndrome Rheumatology, May 1, 2006; 45(5): 621 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Walling, D. C. Woolley, C. Molgaard, and K. J. Kallail Patient Satisfaction with Migraine Management by Family Physicians J Am Board Fam Med, November 1, 2005; 18(6): 563 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Nissan and M. L. Diamond Advances in Migraine Treatment J Am Osteopath Assoc, April 1, 2005; 105(4_suppl): 9S - 15S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S.V. Elkind and A. I. Scher Migraine and cognitive function: Some reassuring news Neurology, February 22, 2005; 64(4): 590 - 591. [Full Text] [PDF]
|
|
|
|
|
|
D. Gaist, L. Pedersen, C. Madsen, I. Tsiropoulos, S. Bak, S. Sindrup, M. McGue, B. K. Rasmussen, and K. Christensen Long-term effects of migraine on cognitive function: A population-based study of Danish twins Neurology, February 22, 2005; 64(4): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Azarbal, J. Tobis, W. Suh, V. Chan, C. Dao, and R. Gaster Association of interatrial shunts and migraine headaches: Impact of transcatheter closure J. Am. Coll. Cardiol., February 15, 2005; 45(4): 489 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Scher, W. F. Stewart, and R. B. Lipton Caffeine as a risk factor for chronic daily headache: A population-based study Neurology, December 14, 2004; 63(11): 2022 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yanguela, M. Sanchez-del-Rio, A. Bueno, A. Espinosa, P. Gili, N. Lopez-Ferrando, F. Barriga, J. C. Nieto, and J. A. Pareja Primary trochlear headache: A new cephalgia generated and modulated on the trochlear region Neurology, April 13, 2004; 62(7): 1134 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kwak, K. D. Vuong, and J. Jankovic Migraine Headache in Patients With Tourette Syndrome Arch Neurol, November 1, 2003; 60(11): 1595 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Brandes Treatment approaches to maximizing therapeutic response in migraine Neurology, October 28, 2003; 61(90084): S21 - 26. [Abstract] [Full Text]
|
|
|
|
|
|
R.B. Lipton, D. Dodick, R. Sadovsky, K. Kolodner, J. Endicott, J. Hettiarachchi, and W. Harrison A self-administered screener for migraine in primary care: The ID MigraineTM validation study Neurology, August 12, 2003; 61(3): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.B. Lipton, A.I. Scher, T.J. Steiner, M.E. Bigal, K. Kolodner, J.N. Liberman, and W.F. Stewart Patterns of health care utilization for migraine in England and in the United States Neurology, February 11, 2003; 60(3): 441 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Khan Migraine-Type Headaches in Children Receiving Chemotherapy and Ondansetron J Child Neurol, November 1, 2002; 17(11): 857 - 858. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
